Effectiveness of Total Hip Arthroplasty for Patients With Osteoarthritis, a Target Trial Emulation Study
EAGLE
1 other identifier
observational
156
1 country
1
Brief Summary
The aim of this study is to assess the effect of total hip arthroplasty on hip disability and pain compared to non-surgery in patients with hip osteoarthritis, using target trial emulation to emulate a randomized controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 24, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 24, 2023
CompletedFirst Submitted
Initial submission to the registry
January 12, 2024
CompletedFirst Posted
Study publicly available on registry
February 16, 2024
CompletedFebruary 16, 2024
February 1, 2024
Same day
January 12, 2024
February 8, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Hip disability and Osteoarthritis Outcome Score Physical function Short form (HOOS-PS), change score from baseline
Ranging from 0 (no difficulty) to 100 (extreme difficulty)
3 months
Secondary Outcomes (1)
Numerical Rating Scale (NRS) pain during weight bearing, change score from baseline
3 months
Study Arms (2)
Total hip arthroplasty (THA)
Total hip arthroplasty surgery
Non-Total hip arthroplasty (THA)
No total hip arthroplasty surgery performed / control group.
Interventions
Unilateral primary total hip arthroplasty procedure.
Eligibility Criteria
Patients with hip osteoarthritis, eligible for primary total hip arthroplasty.
You may qualify if:
- Patients on the waiting list for primary THA between 1-4-2020 up until 31-3-2022 in OLVG or Martini hospital.
- Completed intake questionnaire (HOOS-PS baseline)
- Indication osteoarthritis of the hip
You may not qualify if:
- Patients that received THA on both sides within follow-up (1-4-2020 and 1-1-2022) will be excluded.
- Patients with other indications than osteoarthritis of the hip were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- JointResearchlead
Study Sites (1)
OLVG
Amsterdam, North Holland, 1090 HM, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rudolf Poolman, Prof.
OLVG
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. dr.
Study Record Dates
First Submitted
January 12, 2024
First Posted
February 16, 2024
Study Start
May 24, 2023
Primary Completion
May 24, 2023
Study Completion
May 24, 2023
Last Updated
February 16, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share